Human interleukin-22, a novel member of the cytokine family, has been crystallized in hanging drops using the vapour-diffusion technique. Preliminary X-ray diffraction experiments using synchrotron radiation reveal that the protein crystallizes in space group P2 1 2 1 2 1 , with unit-cell parameters a = 55.44, b = 61.62, c = 73.43 A Ê , and diffracts beyond 2.00 A Ê resolution.
Introduction
Interleukin-22 , also known as interleukin-10-related T-cell-derived inducible factor (IL-TIF), a protein which shares 22% identity with interleukin-10 (IL-10), has been recently identi®ed in interleukin-9 (IL-9) induced murine T cells (Dumoutier, Louahed et al., 2000) and subsequently in human cells (Dumoutier, Van Roost, Colau et al., 2000) as a novel member of the cytokine family. In vitro experiments showed that expression of IL-22 is rapidly induced by IL-9 in T cells, with maximal levels reached in 1 h, and that this induction does not require protein synthesis as the upregulation of the IL-22 mRNA is not blocked by cycloheximide (Dumoutier, Louahed et al., 2000) . This new protein, like other cytokines, has an approximate size of 20 kDa and an N-terminal hydrophobic signal peptide. Human and mouse share 79% amino-acid sequence identity and both have 179 amino-acid residues.
Cytokines exert their actions by binding to speci®c cell-surface receptors, which leads to the activation of cytokine-speci®c signal transduction pathways. Two distinct receptor chains from the class II cytokine receptor family have been identi®ed as taking part in the IL-22±receptor complex (Xie et al., 2000; Kotenko et al., 2001) . These receptors are the CRF2-9 (IL22-R) and the CRF2-4 (IL-10R2 or IL-10R), the latter also being a functional component of the IL-10 signalling complex (Kotenko et al., 1997) . This is the ®rst scienti®c observation within the class II cytokine receptor family of a receptor being utilized as a component of multiple distinct cytokine signalling complexes.
It has been demonstrated in vivo that mIL-22 expression is rapidly increased in several mice organs after lipopolysaccharide (LPS) injection, indicating that the role of IL-22 may not be restricted to the immune system and that it is also involved in in¯am-matory responses (Dumoutier, Van Roost, Colau et al., 2000) . The latter is corroborated by the fact that IL-22 stimulation of HepG2 human hepatoma cells up-regulated the production of acute phase reactants such as serum amyloid A, 1-antichymotrypsin and haptoglobin (Dumoutier, Van Roost, Colau et al., 2000) . Moreover, there are data linking IL-22 to asthma and allergy owing to the probable involvement of IL-9 in these two pathologies (Temann et al., 1998; McLane et al., 1998; Levitt et al., 1999) . Other evidence for this linkage could be obtained at the DNA level. The hIL-22 gene is located on chromosome 12q (Dumoutier, Van Roost, Ameye et al., 2000) , where several loci potentially linked to asthma have been identi®ed (Cookson, 2000) .
In this paper, we describe the crystallization and results of preliminary X-ray diffraction studies of recombinant hIL-22 (rhIL-22) at 2.00 A Ê resolution.
Protein purification
Human IL-22 (corresponding to amino acids Gln29±Ile179; without the signal peptide) was cloned and expressed in Escherichia coli strain BL21 codon plus-(DE3)-RIL (Stratagene) as described in Dumoutier, Van Roost, Colau et al. (2000) . Cells containing rhIL-22 were disrupted and inclusion bodies were collected by centrifugation. They were washed extensively ®rst with 50 mM Tris±HCl, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.5%(w/v) deoxycholate (DOC) pH 8 and ®nally with the same buffer without detergent. Inclusion bodies were solubilized overnight in 8 M urea, 50 mM MES, 10 mM EDTA, 0.1 mM DTT pH 5.5. The rhIL-22 protein was refolded by direct dilution of the solubilized inclusion bodies in the following folding mixture: 100 mg ml À1 rhIL-22, 100 mM Tris±HCl, 2 mM EDTA, 0.5 M l-arginine, 1 mM reduced glutathione, 0.1 mM oxidized glutathione pH 8. The solution was incubated for 72 h. The folding crystallization papers mixture was then concentrated by ultra-®ltration in an Amicon chamber with a YM3 membrane before puri®cation on a Superdex75
(Amersham Pharmacia Biotech) gel-®ltration column. The protein was eluted with 25 mM MES, 150 mM NaCl pH 5.4. Recombinant human IL-22 peak fractions were concentrated to 5 mg ml À1 with a YM3 Amicon membrane and desalted using a Hi-Prep 26/10 column (Amersham Pharmacia) with elution buffer containing 10 mM MES pH 5.4. The protein was concentrated again to 5 mg ml À1 and lyophilized in 1 mg fractions.
Crystallization and data collection
Initial crystallization conditions were screened by the sparse-matrix method using the macromolecular crystallization reagent kits Crystal Screen I and II (Hampton Research) at 291 K. Small crystals were found in conditions number 18, 26 and 29 of the Crystal Screen I kit. In each trial, a hanging drop of 1 ml protein solution (10 mg ml À1 in 20 mM MES buffer pH 5.4) was mixed with 1 ml precipitant solution and equilibrated against a reservoir containing 500 ml precipitant solution. Several attempts to improve crystal quality were performed, including pH and precipitant concentration re®nement, detergent addition and macroseeding. Well diffracting crystals were ®nally obtained using a precipitant solution consisting of 0.9 M sodium tartrate, Triton X-100 detergent and 0.1 M HEPES pH 7.5. Two synchrotron X-ray diffraction data sets, one native and one derivative, have been collected for this study. Both data sets were collected using a 345 mm MAR Research image-plate detector at the Brazilian National Synchrotron Light Laboratory protein crystallography beamline (Polikarpov, Perles et al., 1997; by the oscillation method at 100 K. The native crystal was immersed for 30 s in a cryocooling solution (precipitant solution with 15% ethylene glycol), mounted in a rayon loop and¯ash-cooled to 100 K in a cold nitrogen stream. An iodine derivative was prepared following the quick cryosoaking derivatization procedure (Dauter et al., 2000; Nagem et al., 2001) . A single crystal was immersed for 3 min in a cryocooling solution (the same as used for the native crystal) additionally containing 0.125 M sodium iodide and then frozen in a rayon loop in a cold nitrogen-gas stream (100 K). The synchrotron radiation wavelength was set to 1.54 A Ê to optimize the X-ray¯ux and to increase the anomalous signal for the iodine derivative. The initial images of each data set were subjected to the autoindexing routine of DENZO (Otwinowski & Minor, 1997) , which suggested a primitive orthorhombic cell to be the best solution. Following an optimum strategy of data collection suggested by the program marHKL, totals of 103 and 248 of native and iodine-derivative data were collected, respectively. The images were processed and scaled with the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) .
The iodine derivative, contrary to most derivatives prepared by traditional soaks, did not suffer a considerable loss of diffraction power, modi®cation of unit-cell parameters or degradation during its preparation and has a great chance of being isomorphous (Table 1) .
A search for additional heavy-atom derivatives and phase calculations using the SIRAS method are currently under way. Table 1 Native and iodine-derivative crystal data and data-collection statistics.
Values for the highest resolution shell are shown in parentheses.
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